stockportfolio.pro
Abbott Laboratories Free Cash Flow 2007–2025
Abbott Laboratories (ABT) annual free cash flow by fiscal year, computed from SEC filings. Compound growth +4.2%/yr over 18 years.
| Fiscal year | Free Cash Flow | Change (YoY) |
|---|---|---|
| FY 2025 | $7.39B | +16.4% |
| FY 2024 | $6.35B | +25.5% |
| FY 2023 | $5.06B | -35.2% |
| FY 2022 | $7.80B | -9.8% |
| FY 2021 | $8.65B | +51.1% |
| FY 2020 | $5.72B | +27.3% |
| FY 2019 | $4.50B | -8.3% |
| FY 2018 | $4.91B | +10.6% |
| FY 2017 | $4.43B | +113.0% |
| FY 2016 | $2.08B | +12.2% |
| FY 2015 | $1.86B | -28.6% |
| FY 2014 | $2.60B | +19.2% |
| FY 2013 | $2.18B | -71.0% |
| FY 2012 | $7.52B | +0.5% |
| FY 2011 | $7.48B | -3.1% |
| FY 2010 | $7.72B | +24.8% |
| FY 2009 | $6.19B | +8.4% |
| FY 2008 | $5.71B | +61.8% |
| FY 2007 | $3.53B | — |
Source: Abbott Laboratories SEC filings — cash flow statement (10-K). Refreshed nightly.
See the full picture for Abbott Laboratories
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeAbbott Laboratories — frequently asked questions
What is Abbott Laboratories's free cash flow?
Abbott Laboratories (ABT) reported free cash flow of $7.39B for fiscal year 2025, per its SEC filings.
How has Abbott Laboratories's free cash flow changed over time?
Between fiscal 2007 and 2025, ABT's free cash flow grew at roughly 4.2% per year (compound annual rate), from $3.53B to $7.39B.
Where does this data come from?
Figures are computed from Abbott Laboratories's official SEC filings (cash flow statement (10-K)), refreshed nightly. Not investment advice.